01 6Bausch Health, Canada Inc.
02 1Biovail Pharmaceuticals Canada
03 8GlaxoSmithKline Inc.
04 11Valeant Canada LP
01 102142320
02 102168364
03 12522708
04 22524300
05 12668884
06 12668885
07 12932127
01 4BUPROPION HYDROCHLORIDE | NALTREXONE HYDROCHLORIDE
02 22Bupropion Hydrochloride
01 8Sustained Release Tablet
02 4TABLET (EXTENDED-RELEASE)
03 8Tablet
04 3Tablet (extended release)
05 3tablet (extended release)
01 102013-08-13
02 102014-07-29
03 22023-08-08
04 12024-04-21
05 22027-11-08
06 12034-12-04
Patent Expiration Date : 2013-08-13
Date Granted : 2001-10-09
Brand Name : ZYBAN
Patent Number : 2142320
Filing Date : 1993-08-13
Strength per Unit : 150 mg
Dosage Form : Sustained Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-08-13
Date Granted : 2001-10-09
Patent Expiration Date : 2014-07-29
Date Granted : 2001-09-18
Brand Name : ZYBAN
Patent Number : 2168364
Filing Date : 1994-07-29
Strength per Unit : 150 mg
Dosage Form : Sustained Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-07-29
Date Granted : 2001-09-18
Patent Expiration Date : 2014-07-29
Date Granted : 2001-09-18
Brand Name : WELLBUTRIN SR
Patent Number : 2168364
Filing Date : 1994-07-29
Strength per Unit : 50 mg
Dosage Form : Sustained Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-07-29
Date Granted : 2001-09-18
Patent Expiration Date : 2013-08-13
Date Granted : 2001-10-09
Brand Name : WELLBUTRIN SR
Patent Number : 2142320
Filing Date : 1993-08-13
Strength per Unit : 50 mg
Dosage Form : Sustained Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-08-13
Date Granted : 2001-10-09
Patent Expiration Date : 2014-07-29
Date Granted : 2001-09-18
Brand Name : WELLBUTRIN SR
Patent Number : 2168364
Filing Date : 1994-07-29
Strength per Unit : 150 mg
Dosage Form : Sustained Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-07-29
Date Granted : 2001-09-18
Patent Expiration Date : 2013-08-13
Date Granted : 2001-10-09
Brand Name : WELLBUTRIN SR
Patent Number : 2142320
Filing Date : 1993-08-13
Strength per Unit : 150 mg
Dosage Form : Sustained Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-08-13
Date Granted : 2001-10-09
Patent Expiration Date : 2013-08-13
Date Granted : 2001-10-09
Brand Name : WELLBUTRIN XL
Patent Number : 2142320
Filing Date : 1993-08-13
Strength per Unit : 150 mg
Dosage Form : Tablet (extended release)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-08-13
Date Granted : 2001-10-09
Patent Expiration Date : 2014-07-29
Date Granted : 2001-09-18
Brand Name : WELLBUTRIN XL
Patent Number : 2168364
Filing Date : 1994-07-29
Strength per Unit : 150 mg
Dosage Form : Tablet (extended release)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-07-29
Date Granted : 2001-09-18
Patent Expiration Date : 2023-08-08
Date Granted : 2008-10-28
Brand Name : WELLBUTRIN XL
Patent Number : 2524300
Filing Date : 2003-08-08
Strength per Unit : 150 mg
Dosage Form : Tablet (extended release)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-08-08
Date Granted : 2008-10-28
Patent Expiration Date : 2013-08-13
Date Granted : 2001-10-09
Brand Name : WELLBUTRIN XL
Patent Number : 2142320
Filing Date : 1993-08-13
Strength per Unit : 300 mg
Dosage Form : tablet (extended release)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-08-13
Date Granted : 2001-10-09
